Acute respiratory distress syndrome (ARDS) remains a common complication associated
with significant negative outcomes in critically ill patients. Lung-protective mechanical …

ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) is an acute and diffuse
inflammation of the lung causing severe respiratory failure and has been characterized as a …

Over the last decade, the management of acute respiratory distress syndrome (ARDS) has
made considerable progress both regarding supportive and pharmacologic therapies. Lung …

Introduction There is still no definite drug for acute respiratory distress syndrome (ARDS)
that is capable of reducing either short-term or long-term mortality. Therefore, great efforts …

Despite considerable research and constantly emerging treatment modalities, the mortality
associated with acute respiratory distress syndrome (ARDS) has remained virtually …

Overall, there is no proven pharmacological therapy in ARDS, but some pharmacological
interventions were associated with beneficial effects in certain subgroups of patients …

Acute respiratory distress syndrome (ARDS) is an inflammatory process caused by a variety
of direct and indirect injuries to the lungs. Despite improvements in supportive care and …

Acute respiratory distress syndrome (ARDS) is a life-threatening condition that affects
patients admitted in the Intensive Care Units (ICUs) under mechanical ventilation. ARDS is a …

Acute respiratory distress syndrome (ARDS) presents as an acute inflammatory lung injury
characterized by refractory hypoxemia and non-cardiac pulmonary edema. An estimated …

Importance A number of interventions are available to manage patients with moderate to
severe acute respiratory distress syndrome (ARDS). However, the associations of currently …